Sign in
4

Changes in Ownership

BECTON DICKINSON & CO Filed Acc 0001628280-26-003734

EVP, CRO & Pres. Life Sciences sold 75 shares at $202.73 ($15,205)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Feld Michael · EVP, CRO & Pres. Life Sciences

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-26 Sale : show line 1 in the form 10b5-1 −75 $202.73 $15,205 16,431 D
Open-market sales · 75 sh · avg $202.73 · $15,205
Loading xslF345X05/wk-form4_1769611611.xml…